Aisling Capital Management as of Dec. 31, 2024
Portfolio Holdings for Aisling Capital Management
Aisling Capital Management holds 15 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bridgebio Pharma (BBIO) | 59.1 | $167M | 6.1M | 27.44 | |
| Verona Pharma Sponsored Ads (VRNA) | 18.4 | $52M | 1.1M | 46.44 | |
| Syndax Pharmaceuticals (SNDX) | 4.8 | $14M | 1.0M | 13.22 | |
| Monte Rosa Therapeutics (GLUE) | 3.6 | $10M | 1.5M | 6.94 | |
| Poseida Therapeutics I (PSTX) | 3.6 | $10M | 1.0M | 9.60 | |
| Bicara Therapeutics (BCAX) | 3.5 | $9.9M | 569k | 17.42 | |
| Nuvation Bio Com Cl A (NUVB) | 2.4 | $6.8M | 2.5M | 2.66 | |
| Compass Pathways Sponsored Ads (CMPS) | 1.3 | $3.6M | 965k | 3.78 | |
| Biomea Fusion (BMEA) | 1.1 | $3.1M | 799k | 3.88 | |
| CalciMedica Com New (CALC) | 0.7 | $1.8M | 521k | 3.54 | |
| Elevation Oncology (ELEV) | 0.6 | $1.6M | 2.8M | 0.56 | |
| Aclaris Therapeutics (ACRS) | 0.4 | $1.1M | 435k | 2.48 | |
| Marker Therapeutics Com New (MRKR) | 0.4 | $1.0M | 325k | 3.11 | |
| OnKure Therapeutics Com Cl A (OKUR) | 0.3 | $762k | 89k | 8.60 | |
| Viracta Therapeutics (VIRX) | 0.0 | $46k | 289k | 0.16 |
